EFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIALEFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIAL
Laurent Peyrin-Biroulet 1
Iris Dotan 2
Alessandra Oortwijn 3
Brian Feagan 4
Toshifumi Hibi 5
Virginia Taliadouros 3
Sally Zhao 6
Jie Zhang 7
Jeremy Hsieh
1 Nancy University Hospital,Nancy,France
2 Rabin Medical Centre,Petah Tikva,Israel
3 Galapagos NV,Leiden,Netherlands
4 Alimentiv Inc.,London, Ontario,Canada
5 Kitasato Institute Hospital, Kitasato University,Tokyo,Japan
6 Gilead Sciences, Inc.,Foster City,United States
7 Gilead Sciences, Inc.,Foster City,Uni
Session
IBD: Clinical trials IV
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing